Thirty Madison, a New York-based telehealth company, focusing on treating chronic health conditions, raised $47 million Series B funding. Polaris Partners led the funding with
CancerIQ Raises $5M in VC Funding
CancerIQ, a provider of precision health platform for cancer risk assessment to hospitals, raised $4.8 million in Series A. Health-focused venture capital firm HealthX Ventures
Funding and M&A Roundup: Sunamp Raises £4.5 Million in a Series A Financing Round
Here are some of the important funding and M&A updates of last week from the global renewable energy industry: Sonnedix, an independent solar power producer
Health Catalyst Acquires Revenue Workflow Optimization Startup Vitalware
Health Catalyst, a provider of data and analytics technology and services to healthcare organizations, entered into a definitive agreement to acquire Vitalware, a provider of
Eden Health Raises $25 Million to Expand Virtual Healthcare to Employers
Eden Health, a direct-to-employer telehealth platform, raised $25 million in Series B funding. The company partners with employers to offer telehealth services to their employees.
Telehealth Company Cecelia Health Raises $13 Million
Cecelia Health, a provider of telehealth services for diabetes and other chronic diseases, completed a $13 million Series B funding round. Rittenhouse Ventures and Endo
Cervical Cancer Screening Tool Maker MobileODT Raises $4 Million
MobileODT, a provider of an AI-powered smart cervical cancer screening device – Colposcope, raised $4 million Series C funding round. With the latest round, the
Healthcare Practice Management Company Lumeon Raises $30 Million
Lumeon, a digital health company specializing in care pathway orchestration, closed a $30 million Series D funding round. The funding was led by new investors
Medtronic Acquires Smart Insulin Pen Company Companion Medical
Medtronic, an Irish-domiciled medical device company, agreed to acquire Companion Medical, manufacturer of InPen – an FDA-cleared smart insulin pen system paired with an integrated
Online Birth Control Prescription Company Nurx Raises $22.5 Million
Nurx, a telemedicine platform that offers birth control prescriptions, raised an additional $22.5 million in Series C funding, bringing its C round to $74.5 million.